Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

August 29-30, 2018

4th International Conference on Cytopathology & Histopathology

Boston | Massachusetts | USA
August 31 - September 01, 2018

International Conference and Expo on Dermatopathology and Skin Care

Toronto, Canada
September 17-18, 2018

16th Asia Pacific Pathology Congress

Tokyo, Japan
October 15-16, 2018

3rd International Conference on Internal Medicine & Hospital Medicine

Ottawa, Ontario, Canada
October 18-19, 2018

European Pathology and Infectious Disease Conference

Helsinki, Finland
March 22-23, 2019 |

World Birth Congress

New York, USA
(14 Forums, 2 Days, 1 Event)
April 22-23, 2019

16th Annual Conference on Laboratory Medicine & Pathology

Kuala Lumpur, Malaysia
May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in